cytarabine has been researched along with cyclopentane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carew, JS; Carraway, H; Keaton, M; Kelly, KR; Maciejewski, JP; Nawrocki, ST; Sekeres, MA; Smith, PG | 1 |
Finn, LE; Foran, JM; Hess, AD; Karp, JE; Kaufmann, SH; Knorr, KL; Smith, BD | 1 |
2 other study(ies) available for cytarabine and cyclopentane
Article | Year |
---|---|
The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine.
Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cyclopentanes; Cytarabine; Drug Synergism; Gene Knockdown Techniques; Humans; Mice, Nude; NEDD8 Protein; Nucleotides; Protein Stability; Pyrimidines; Ubiquitins; Xenograft Model Antitumor Assays | 2015 |
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.
Topics: Cell Count; Cell Death; Cell Survival; Cyclopentanes; Cytarabine; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Pyrimidines | 2017 |